News

CRLX101, a tumor-targeted nanopharmaceutical, is a dual inhibitor of topoisomerase 1 and hypoxia-inducible factor-1a and releases camptothecin over an extended period of time. The randomized study, which is

The Form 10 Registration Statement includes the significant information about Mallinckrodt and the separation, which contains an overview of the businesses in which Mallinckrodt will operate and of

Under the agreement, MDH will utilize Sectra Breast Imaging PACS to provide remote reading of mammograms to its customers. The agreement also covers Volpara’s integrated breast density software,

Oxtellar XR, a once-daily extended release formulation of oxcarbazepine, is an antiepileptic drug (AED), which is available in 150 mg, 300 mg and 600 mg dosage strengths. The

The partnership will deliver more robust, insight-based strategic RM outcomes by leveraging Appature’s enablement of Big Data and cloud-based marketing platform and DKI’s expertise in building meaningful relationship

The company leverages 3D bioreactor technology in the production of the PLX cells to tackle issues such as reproducibility, production costs and quality. Pluristem chairman and CEO Zami

The FDA-approved facilities in the US, will manufacture Live Young Naturals product line. Hokutou CEO Eugene Collins said 70% of US adults use dietary supplements, and over $30bn

According to the company, from the €2.6m grant it will receive €215.000, which would be used in its ongoing three year project of determining the clinical value of

As part of the acquisition, the tendered shares were also transferred to BASF. In addition, BASF is setting up a compulsory acquisition process (squeeze out) to acquire the